Company: BLNE
Filing Date: 2025-11-14
Form Type: 424B3
Source: 0001493152-25-023493
Chunk: 29

Company: Beeline Holdings, Inc.
Filing Date: 2025-11-14
Form: 424B3
Chunk 29
---
 retain the Stated Percentage of shares issuable on conversion of the Series F and Series F-1 relative to Measuring Shares of 82.5%. All adjustments are subject to a floor price equal to 20% of the Minimum Price as defined in the Nasdaq Rules as long as the common stock trades on Nasdaq.

In connection with the adjustment provisions described above for a period of one year from the issuance date, 10% of the shares of common stock underlying the Series F and Series F-1 are subject to lock-up restrictions, and potential reduction in the underlying shares of common stock to the extent the Measuring Shares are less than the Maximum Amount, which if applicable will apply on a pro rata basis as to the holders thereof so as to preserve the Stated Percentage.

If our common stock is de-listed from Nasdaq, the various stockholder approvals will not be required for conversion and exercise, except for the increase in authorized common stock.

| 22 |

Series G

Each share of Series G has a stated value of $0.51. In the event of a liquidation of Beeline, the holders of Series G will share in the distribution of Beeline’s net assets on an as-converted basis, subordinate only to the Series B, Series D and Series E.

Following stockholder approval of the full conversion of the Series G at the Company’s annual stockholders meeting on October 2, 2025, each share of Series G is convertible into common stock by a conversion ratio equal to the stated value of the Series G share divided by the Series G conversion price. Presently 975,884 shares of Series G are convertible as the result of a prior approval by our stockholders. The initial Series G conversion price was $5.10 per share, and the current conversion price as a result of price protection adjustments is $1.67. The Series G conversion price is subject to equitable adjustment in the event of a stock split, reverse split and similar events. The number of shares of common stock into which a holder may convert Series G will be limited by a 4.99% beneficial ownership limitation.

On June 16, 2025, the Company sold shares of common stock at $0.66 per share, which was less than the exercise price of the Warrants, issued in connection with the sale of Series G, initially sold at $6.50, resulting in the reduction of the exercise price of the warrants to $0.66 per share and common shares issuable upon exercise